enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$7.19 USD
+0.33 (4.81%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $7.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
enGene Holdings Inc. (ENGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$30.83 | $40.00 | $17.00 | 349.42% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for enGene Holdings Inc. comes to $30.83. The forecasts range from a low of $17.00 to a high of $40.00. The average price target represents an increase of 349.42% from the last closing price of $6.86.
Analyst Price Targets (6 )
Broker Rating
enGene Holdings Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, six are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/11/2024 | UBS | Trung Huynh | Not Available | Strong Buy |
8/28/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/14/2024 | SVB Securities | Mani Foroohar | Strong Buy | Strong Buy |
4/22/2024 | Wells Fargo Securities | Yanan Zhu | Not Available | Strong Buy |
4/15/2024 | Guggenheim Securities | Michael Schmidt | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 6 |
Average Target Price | $30.83 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 252 |
Current Quarter EPS Est: | -0.43 |
ENGN FAQs
enGene Holdings Inc. (ENGN) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for enGene Holdings Inc. (ENGN) is $30.83. The current on short-term price targets is based on 3 reports.
The forecasts for enGene Holdings Inc. (ENGN) range from a low of $17 to a high of $40. The average price target represents a increase of $328.79 from the last closing price of $7.19.
The current UPSIDE for enGene Holdings Inc. (ENGN) is 328.79%
Based on short-term price targets offered by six analysts, the average price target for enGene Holdings Inc. comes to $30.83. The forecasts range from a low of $17.00 to a high of $40.00. The average price target represents an increase of 349.42% from the last closing price of $6.86.